Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CTRP4/interleukin-6 receptor signaling ameliorates autoimmune encephalomyelitis by suppressing Th17 cell differentiation
Lulu Cao, … , Xiaoxin Zhu, Lu Wang
Lulu Cao, … , Xiaoxin Zhu, Lu Wang
Published November 28, 2023
Citation Information: J Clin Invest. 2024;134(4):e168384. https://doi.org/10.1172/JCI168384.
View: Text | PDF
Research Article Autoimmunity

CTRP4/interleukin-6 receptor signaling ameliorates autoimmune encephalomyelitis by suppressing Th17 cell differentiation

  • Text
  • PDF
Abstract

C1q/TNF-related protein 4 (CTRP4) is generally thought to be released extracellularly and plays a critical role in energy metabolism and protecting against sepsis. However, its physiological functions in autoimmune diseases have not been thoroughly explored. In this study, we demonstrate that Th17 cell–associated experimental autoimmune encephalomyelitis was greatly exacerbated in Ctrp4–/– mice compared with WT mice due to increased Th17 cell infiltration. The absence of Ctrp4 promoted the differentiation of naive CD4+ T cells into Th17 cells in vitro. Mechanistically, CTRP4 interfered with the interaction between IL-6 and the IL-6 receptor (IL-6R) by directly competing to bind with IL-6R, leading to suppression of IL-6–induced activation of the STAT3 pathway. Furthermore, the administration of recombinant CTRP4 protein ameliorated disease symptoms. In conclusion, our results indicate that CTRP4, as an endogenous regulator of the IL-6 receptor–signaling pathway, may be a potential therapeutic intervention for Th17-driven autoimmune diseases.

Authors

Lulu Cao, Jinhai Deng, Wei Chen, Minwei He, Ning Zhao, He Huang, Lu Ling, Qi Li, Xiaoxin Zhu, Lu Wang

×

Figure 1

Ctrp4 deficiency perturbs T cell homeostasis.

Options: View larger image (or click on image) Download as PowerPoint

Ctrp4 deficiency perturbs T cell homeostasis.
(A) Surface staining of C...
(A) Surface staining of CD4 and CD8 on Ctrp4–/– or WT thymocytes. Numbers in quadrants indicate the percentages of different stage cells, including CD4–CD8– DN, CD4+CD8+ DP, CD8–CD4+ single-positive, and CD4–CD8+ single-positive T cells (n = 10 animals per group from 1 representative experiment of 3). (B) Flow cytometry analysis of the transition between the different populations of DN T cell precursors in the thymus, which were marked by the differential expression of CD44 and CD25. DN1:CD44+CD25–, DN2:CD44+CD25+; DN3:CD44–CD25+; DN4: CD44–CD25–. (C and D) Representative plots showed the percentages of naive (CD44loCD62Lhi) and memory/effector (CD44hiCD62Llo) CD4+ T cells (C) and CD8+ T cells (D) in the spleens of Ctrp4–/– or WT mice. (E) Flow cytometry analyses of Th1 (IFN-γ+) and Th17 (IL-17A+) effector T cells in the spleens of Ctrp4–/– and WT mice (n = 5/group). Data are represented as the frequency of CD4+CD44+ cells. (F) Gene expression of Il17a, Il17f, Rorc, or Ctrp4 mRNA in CD4+ T cells from Ctrp4–/– or WT mice (n = 5/group) were analyzed by quantitative real-time PCR. Values were normalized against Gapdh. Data are represented as mean ± SEM and are from 1 of 3 independent experiments with similar results. Statistical significance was determined using 2-tailed, unpaired Student’s t test or Mann-Whitney U test as appropriate after assessing for distribution. *P < 0.05; **P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts